How representative are clinical trial cohorts of the general CF population? Implications for trial planning.

Dobra, Rebecca; Pinnell, Sophie; Jones, Andy; Madge, Susan; Simmonds, Nicholas J; Davies, Jane C

Dobra, Rebecca; Pinnell, Sophie; Jones, Andy; Madge, Susan; Simmonds, Nicholas J; Davies, Jane C.

Afiliación

Dobra R; Imperial College London, United Kingdom. Electronic address: r.dobra@rbht.nhs.uk.
Pinnell S; Imperial College London, United Kingdom.
Jones A; Imperial College London, United Kingdom.
Madge S; Imperial College London, United Kingdom.
Simmonds NJ; Imperial College London, United Kingdom.
Davies JC; Imperial College London, United Kingdom.

J Cyst Fibros ; 23(1): 68-72, 2024 Jan.

Article en En | MEDLINE | ID: mdl-38040535

Asunto(s)

Fibrosis Quística; Humanos; Niño

Palabras clave

Clinical trials eligibility; Trial design

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrosis Quística Límite: Child / Humans Idioma: En Revista: J Cyst Fibros Año: 2024 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google